Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
ACG appoints Rafael Costa as Vice President Sales for the Americas Region
Friday, January 27, 2023ACG a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries is pleased to announce the appointment of Rafael Costa as Vice President for the Americas region In his new role Rafael Costa...
Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
Thursday, January 26, 2023ProBioGen today announced that a Novartis clinical candidate using its antibodydependent cellular cytotoxicity ADCC technology GlymaxX has reached Phase III ProBioGens mission is to contribute towards the development of medicines against complex dise...
Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors
Thursday, January 26, 2023Centessa Pharmaceuticals plc a clinicalstage pharmaceutical company that aims to discover and develop medicines that are transformational for patients today announced that it has received clearance of its Investigational New Drug IND application from...
Aspargo Receives Regulatory Approval to Market Sildenafil Spray in Germany, Ireland, and The Netherlands
Tuesday, January 24, 2023Aspargo Laboratories Inc a privately held specialty pharmaceutical company focused on commercializing innovative formulations of leading tablet medications announced today that the German Federal Institute for Drugs and Medical Devices has authorized...
Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
Tuesday, January 24, 2023Core One Labs Inc in followup to its press release dated September is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd Akome has finalized study parameters and signed a contract with Fundaci Bosh I Gimpera in representation of...
First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated
Monday, January 23, 2023OxSonics Therapeutics a clinicalstage medtech company focused on transforming cancer treatment through SonoTran its proprietary ultrasoundbased drug delivery platform today announces that firstinhuman clinical data demonstrated that SonoTran is safe...
Blueprint Medicines Announces FDA Acceptance of Supplemental New Drug Application for AYVAKIT® (avapritinib) for the Treatment of Indolent Systemic Mastocytosis
Monday, January 23, 2023Blueprint Medicines Corporation announced that the US Food and Drug Administration FDA has accepted the companys supplemental new drug application for AYVAKIT avapritinib for the treatment of adults with indolent systemic mastocytosis SM The FDA gran...
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
Monday, January 23, 2023BiondVax Pharmaceuticals Ltd a biotechnology company focused on developing manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases today announced additional results in...
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
Thursday, January 19, 2023Synlogic Inc the leading company advancing therapeutics based on synthetic biology today announced that SYNB was granted Rare Pediatric Disease Designation RPDD by the US Food and Drug Administration FDA for the potential treatment of phenylketonuria...
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
Thursday, January 19, 2023AbCellera announced that the United States Patent and Trademark Offices Patent Trial and Appeal Board PTAB has ruled in favor of AbCellera in an Inter Partes Review IPR filed by Berkeley Lights Inc Berkeley Lights that challenged AbCelleras US Patent...
